This week's collection of venture capital financings in the biotech arena includes rounds for Celea, Beeline, Flare, Lycia, and Telum. PureTech's Celea eyes phase 3 for IPF drug a ...
Whatever its intensity, it should never be considered "normal." To understand why erections can become painful, it's helpful ...
Less than six months into his 20-year prison sentence, the former sheriff’s deputy convicted of second-degree murder for the ...
Poo may be something we flush and forget, but it can reveal a surprising amount about your health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results